Treatment And Prevention Of Neuropathic Pain With P2Y14 Antagonists
US Patent 11,708,346
Filed on 2020-07-23
Filed on 2020-07-23
HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS
US Patent 11,584,736
Filed on 2020-08-04
Filed on 2020-08-04
HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS
Japan
2020-542580
Filed on 2020-08-06
2020-542580
Filed on 2020-08-06
HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS
European Patent
19707559.1
Filed on 2020-07-20
19707559.1
Filed on 2020-07-20
HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS
China
201980012696.0
Filed on 2020-08-10
201980012696.0
Filed on 2020-08-10
HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS
Canada
3090788
Filed on 2020-08-07
3090788
Filed on 2020-08-07
HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS
Australia
2019218256
Filed on 2020-07-28
2019218256
Filed on 2020-07-28
A1 ADENOSINE RECEPTOR AGONISTS AND METHODS OF USE THEREOF
Patent Cooperation Treaty
PCT/US2019/064844
Filed on 2019-12-06
PCT/US2019/064844
Filed on 2019-12-06
COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS
Hong Kong
19127110.5
Filed on 2017-04-21
19127110.5
Filed on 2017-04-21
PURINE AND PYRIMIDINE NUCLEOTIDES AS ECTO-5’-NUCLEOTIDASE INHIBITORS
Patent Cooperation Treaty
PCT/US2019/046931
Filed on 2019-08-16
PCT/US2019/046931
Filed on 2019-08-16